Karuna Therapeutics

Clinical-stage biopharmaceutical company.

Based in MA

🤖

AI Overview

With $530K in lobbying spend across 11 quarterly filings, Karuna Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2024.

$530K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$230K
2023$200K
2024$100K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Karuna Therapeutics disclosed contacting in their lobbying filings.

SENATEHOUSE OF REPRESENTATIVES
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Education around innovation in Schizophrenia.

Education around innovation in mental health treatment, especially in Schizophrenia

Education around innovation in mental health treatment, especially in Schizophrenia.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.